Hypertrophic cardiomyopathy
BJ Maron, MS Maron - The Lancet, 2013 - thelancet.com
Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one
in 500 of the general population. It is caused by more than 1400 mutations in 11 or more …
in 500 of the general population. It is caused by more than 1400 mutations in 11 or more …
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
S Wordsworth, J Leal, E Blair, R Legood… - European heart …, 2010 - academic.oup.com
Aims To explore the cost-effectiveness of alternative methods of screening family members
for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and …
for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and …
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership …
MJ Ackerman, SG Priori, S Willems, C Berul… - Europace, 2011 - academic.oup.com
1From Mayo Clinic, Rochester, Minnesota; 2Fondazione Salvatore Maugeri University of
Pavia, Pavia, Italy and New York University, New York, New York; 3University Hospital …
Pavia, Pavia, Italy and New York University, New York, New York; 3University Hospital …
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases
P Elliott, B Andersson, E Arbustini… - European heart …, 2008 - academic.oup.com
In biology, classification systems are used to promote understanding and systematic
discussion through the use of logical groups and hierarchies. In clinical medicine, similar …
discussion through the use of logical groups and hierarchies. In clinical medicine, similar …
Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy
Objectives: The aim of this study was to examine the value of native and post-contrast T1
relaxation in the differentiation between healthy and diffusely diseased myocardium in 2 …
relaxation in the differentiation between healthy and diffusely diseased myocardium in 2 …
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy
Aims Risk stratification algorithms for sudden cardiac death (SCD) in hypertrophic
cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time …
cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time …
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American registry
SF Nagueh, BM Groves, L Schwartz, KM Smith… - Journal of the American …, 2011 - jacc.org
Objectives: The purpose of the study is to identify the predictors of clinical outcome (mortality
and survival without repeat septal reduction procedures) of alcohol septal ablation for the …
and survival without repeat septal reduction procedures) of alcohol septal ablation for the …
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy
MS Maron, EJ Rowin, D Lin, E Appelbaum… - Circulation …, 2012 - Am Heart Assoc
Background—In hypertrophic cardiomyopathy (HCM), cardiovascular MR can detect
morphological abnormalities of the left ventricle (LV) not visualized with echocardiography …
morphological abnormalities of the left ventricle (LV) not visualized with echocardiography …
Right ventricular involvement in hypertrophic cardiomyopathy
MS Maron, TH Hauser, E Dubrow, TA Horst… - The American journal of …, 2007 - Elsevier
The aim of this study was to assess, using cardiovascular magnetic resonance (CMR),
whether morphologic right ventricular (RV) abnormalities are present in patients with …
whether morphologic right ventricular (RV) abnormalities are present in patients with …
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors
BJ Maron, MS Maron, C Semsarian - Heart rhythm, 2012 - Elsevier
BACKGROUND: Risk stratification strategies employing sarcomere gene mutational
analysis have proved imprecise in identifying high-risk patients with hypertrophic …
analysis have proved imprecise in identifying high-risk patients with hypertrophic …